Children and Families Bill Debate
Full Debate: Read Full DebateDavid Nuttall
Main Page: David Nuttall (Conservative - Bury North)Department Debates - View all David Nuttall's debates with the Department of Health and Social Care
(10 years, 9 months ago)
Commons ChamberThat is for the review to comment on. I hope that hon. Members will understand that I am not trying to be unhelpful in not responding in detail to their interventions. We have put in place a process that we think will be the most robust way of making policy in this area, and I hope that the hon. Gentleman will forgive me for not commenting in detail on his point. I am sure that the review is looking in detail at all these aspects; they were certainly explored during the consultation.
Just to finish this point off, will the Minister make it clear that she and her colleagues will consider a wider range of factors alongside the outcome of the review before deciding how to proceed?
That is something we have put on record a number of times, and I can confirm it again tonight. We have always said that Ministers would proceed having received the review and given consideration to all the wider aspects of the policy. I hope that that reassures my hon. Friend.
The requirements would apply only to the retail packaging of tobacco products, which means the packaging that will be, or is intended to be, used when the product is sold to the public. Manufacturers, distributors and retailers would still be able to use branding such as logos and colours on packaging, provided that they were used only within the tobacco trade—for example, on boxes used for stock management in a warehouse that are not seen by the public.
These provisions would apply on a UK-wide basis, as the necessary legislative consent motions have been secured. As I have already said, I will not pre-empt the outcome of Sir Cyril’s review or of the decision-making process, but these provisions mean that we would be able to act without delay if we were to decide to go ahead. I want to emphasise that Sir Cyril will not be making the decision for Ministers on whether to proceed with standardised packaging. That decision will be made by Ministers in the light of the wide range of relevant considerations.
My hon. Friend the Member for Shipley (Philip Davies) has tabled three amendments on standardised packaging. The first five clauses of the packaging provisions set out the test that Ministers will need to consider before bringing forward regulations. The regulation-making powers in the Bill will allow Ministers to take a reasonable and balanced view of the available evidence regarding the effect that regulations as a whole would have on the health and welfare of children. This approach to ministerial decision making is absolutely appropriate and these clauses are in keeping with the approach that Minsters would ordinarily take in decision-making processes of this kind.
My hon. Friend’s three amendments seek to remove the ability of Ministers to take a reasonable and balanced view of the evidence, and we feel that they would put unnecessary and unwarranted constraints on Ministers’ consideration of how any proposed regulations would impact on children’s health or welfare. Constraining Ministers’ decision making in that way would probably have the effect of stopping the use of the powers altogether. For that reason, I do not support my hon. Friend’s amendments. I also remind the House that the regulations would be subject to the affirmative resolution procedure.
I should like to move on to the age of sale for nicotine products. We have introduced provisions for a regulation-making power to prohibit the sale of nicotine products such as e-cigarettes to people under the age of 18. Public health experts, many retailers—particularly small retailers—and the electronic cigarette industry support the introduction of an age of sale restriction for e-cigarettes. At present, no such general legal restriction is in place, and we want to correct this situation.
As e-cigarettes are novel products, we have very little evidence on the impact of children using them. For example, we do not know what impact their use might have on the developing lungs of young people. Public health experts have expressed concern to me that nicotine products could act as a gateway into smoking tobacco, as well as undermining efforts to reshape social norms around tobacco use. Young people can rapidly develop nicotine dependence, and nicotine products deliver nicotine and cause addiction. Attempts were made last year to include an age-of-sale provision applicable throughout the EU in the revised European tobacco products directive, but that was not achieved. We therefore want to take this opportunity to put such a provision in place domestically through this Bill.